Sponsored Content
Ask any DSO leader what they’re optimizing for right now, and one word continues to come up: standardization. Fewer vendors, one clinical standard, predictable costs, and a network that performs the same way whether you’re looking at location one or location fifty. EBITDA sits behind almost all of it: every fragmented vendor relationship, every unpredictable cost line, and every inconsistent outcome drags down the margin a DSO is measured on.
Aesthetics has been the exception. Delivering a truly lifelike restoration has typically required stepping outside a standardized, cost-controlled workflow. It has meant relying on a specialty lab, an individual ceramist, or a material with a completely different cost and turnaround profile. That’s starting to change, and it’s worth understanding what’s driving it, because it speaks directly to the metrics DSO leadership actually reports on.
The tradeoff that’s kept anterior aesthetics from scaling
Since digital workflows took hold in dentistry, zirconia has become the default restorative material for most posterior cases. It’s strong, biocompatible, and priced to support high-volume, standardized production, meeting the exact criteria a DSO needs across every chair in the network.
The catch has always been aesthetics, and it shows up most in anterior cases. Traditional monolithic zirconia crowns are milled from a single block of shaded material, which makes them durable but can leave them looking flat, opaque, or “chalky” next to natural dentition, patients notice immediately in the smile zone.
When a case calls for a higher aesthetic bar, the industry’s answer has been layered porcelain, e.max, or other aesthetic materials — often hand-layered or characterized by a ceramist to recreate the way light moves through a natural tooth. It’s a genuine craft, but one with real clinical tradeoffs: these materials are more prone to chipping and fracture than monolithic zirconia.
Add to that the scarcity of skilled ceramists and the fact that hand-layering can’t be automated without losing the judgment that makes it valuable, and you get a category of restoration that can run two to three times the cost of a monolithic zirconia crown, with longer turnaround attached and a higher remake rate on top of it.
For a single practice, that’s a case-by-case tradeoff. For a DSO, it’s the reason aesthetic cases have been almost impossible to standardize across a network: every location ends up managing its own mix of in-network zirconia and outside specialty lab relationships for aesthetic cases, with no consistent clinical or financial standard tying it together.
What this tradeoff really costs a DSO
For a DSO, this isn’t just an occasional pricier case. It’s a structural cost that plays out differently in every location, with every doctor and every outside lab relationship. The sum of those local decisions is hard to manage centrally or explain in a board deck.
Lab fragmentation. When a general lab can’t deliver the aesthetic outcome a case needs, the workaround is usually a specialty or boutique lab. Multiply that across dozens of practices and you end up with a patchwork of vendor relationships, each with its own pricing, turnaround, and quality standards, undermining the consolidated supply chain most DSOs are trying to build.
High, unpredictable costs. Aesthetic cases priced two to three times higher than standard zirconia, combined with a higher remake rate, make it difficult to forecast lab spend with any precision, and every point of margin lost there shows up directly in EBITDA. When aesthetic case volume varies month to month and location to location, so does the hit.
Inconsistent clinical quality. Because aesthetic outcomes depend heavily on the individual ceramist assigned to a case, the same prescription can come back looking different depending on which lab — or which technician at that lab — touched it. That’s hard to explain to a patient, and harder still to standardize across a brand.
None of this is a failure of any single practice. It’s the natural result of trying to scale a process that has, until now, depended on individual craftsmanship in a business built to run on repeatable systems.
Dandy pioneered a way to close this gap digitally on zirconia
This is where Dandy spent the last three years and more than $100 million: building a patented, digitally-driven shading process that brings porcelain-level aesthetics to high-strength monolithic zirconia.
It’s called Polychromatic Shade™. Rather than applying a single, uniform shade to a milled crown, it builds color in multiple phases, mapping micro-variations in hue, value, and chroma across the restoration. The result is a natural looking restoration with lifelike translucency, gradients from cervical to incisal, and depth that blends naturally in the mouth. All of this is done through a controlled, repeatable, digitally-driven process instead of an individual’s technique.
Because the manufacturing process is proprietary and patented, we’ll describe it at a principles level rather than a technical one: a precise, software-driven color map guides how shade is built up in layers across each restoration, and translucency is engineered to mimic how natural light is absorbed, reflected, and refracted through a tooth. The process combines precision robotics, ceramic science, and machine learning to hit that result with micron-level precision on every single crown, removing the dependence on any one technician’s hand.
What this means for scaling aesthetics across your network
A single practice benefits from a more lifelike crown. A DSO gets something bigger: for the first time, a way to scale aesthetic quality network-wide instead of managing it case by case, location by location. That’s the tradeoff DSOs have never been able to break — until aesthetic outcomes could come from a controlled, digital process instead of an individual ceramist’s hand.
One clinical standard, network-wide. A crown from location twelve can look like a crown from location one, because the shade architecture comes from the same software-driven process rather than whichever technician was assigned that day, extending the standardization DSOs already rely on into aesthetics.
Porcelain aesthetics at zirconia economics. Layered and pressed aesthetic cases from outside specialty labs have historically run two to three times the cost of a standard zirconia crown. Polychromatic Shade™ brings that same natural, lifelike result down to the $99 range, aligning directly with standard monolithic zirconia pricing. On a multi-unit anterior case, that gap adds up fast: over $1,800 in savings compared to an outside aesthetic lab, on a single case, before you even multiply it across every doctor and every location running similar cases.
Lab consolidation. Dentists no longer need to rely on local or boutique labs to get a lifelike result, reducing the specialty vendors that cause network fragmentation. One centralized lab partner can absorb complex anterior cases that used to require a separate outside relationship, replacing a patchwork of vendors with a single, consolidated one.
Fewer remakes. Aesthetic and shade mismatches are one of the more common reasons an anterior crown comes back, and layered or pressed materials add a second failure point on top of that: they’re simply more prone to chipping and fracture than zirconia. A controlled, repeatable shading process on a stronger material addresses both causes of remake at once: saving chair time and protecting margin.
None of this requires clinicians to change their workflow, sacrifice clinical autonomy, or feel poorly about the restorations they are delivering. Doctors can keep prescribing, prepping, and seating cases the way they always have, now with an aesthetic outcome that matches the standard they hold.
What DSO leaders should be asking
If your organization is currently managing aesthetic cases through a mix of in-network labs and outside specialty relationships, it’s worth asking a few questions before your next contract renewal or lab evaluation:
- How many different lab vendors are we using specifically to cover aesthetic or anterior cases, and what would consolidating to one partner do to our administrative overhead?
- Do we have visibility into aesthetic outcome consistency across locations, or is that feedback anecdotal — coming from doctor complaints rather than data?
- What share of our remakes are aesthetic mismatches or material fractures rather than fit or function issues, and what would meaningfully reducing that category do for our EBITDA?
- If we could bring aesthetic cases back in-house to a single digital lab partner, what would that do to our vendor count, our cost predictability, and our ability to guarantee a consistent patient experience network-wide?
Those questions matter for any DSO evaluating its lab strategy, regardless of which partner you land on. What’s changed is that there’s now a real answer to them: a controlled, digital process that brings aesthetic quality to standard zirconia, built and patented by Dandy, and available today to any network ready to standardize on it.
The bottom line
The old tradeoff (paying two to three times more for aesthetics or accepting a flat result) was never a dentistry problem. It was a scale problem, born from a process that depended on individual craftsmanship in an industry that increasingly runs on repeatable systems and answers to EBITDA. Polychromatic Shade™ is the answer to that scale problem: a way to build the depth and vitality of layered porcelain into the zirconia DSOs already trust.
For DSO leaders, aesthetics no longer has to be the exception you manage case by case. It can be the standard you set once and count on everywhere.
